Intrua Financial LLC bought a new position in Colgate-Palmolive (NYSE:CL – Get Rating) in the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor bought 3,470 shares of the company’s stock, valued at approximately $261,000.
Other institutional investors have also recently added to or reduced their stakes in the company. First National Trust Co lifted its position in Colgate-Palmolive by 4.8% in the third quarter. First National Trust Co now owns 5,411 shares of the company’s stock worth $381,000 after purchasing an additional 249 shares during the period. MQS Management LLC bought a new position in shares of Colgate-Palmolive in the third quarter valued at $210,000. Oppenheimer Asset Management Inc. increased its holdings in shares of Colgate-Palmolive by 0.8% in the third quarter. Oppenheimer Asset Management Inc. now owns 22,604 shares of the company’s stock valued at $1,588,000 after buying an additional 187 shares in the last quarter. B. Riley Wealth Management Inc. bought a new position in shares of Colgate-Palmolive in the second quarter valued at $303,000. Finally, National Pension Service increased its holdings in shares of Colgate-Palmolive by 8.2% in the second quarter. National Pension Service now owns 1,209,856 shares of the company’s stock valued at $96,958,000 after buying an additional 91,928 shares in the last quarter. 77.63% of the stock is currently owned by institutional investors and hedge funds.
Analyst Ratings Changes
CL has been the topic of several research reports. Morgan Stanley raised Colgate-Palmolive from an “equal weight” rating to an “overweight” rating and set a $82.00 price target on the stock in a report on Monday, January 30th. TheStreet cut Colgate-Palmolive from a “b” rating to a “c+” rating in a report on Friday, January 27th. StockNews.com raised Colgate-Palmolive from a “hold” rating to a “buy” rating in a report on Friday, March 24th. UBS Group raised their target price on Colgate-Palmolive from $84.00 to $86.00 and gave the stock a “buy” rating in a research report on Wednesday. Finally, JPMorgan Chase & Co. raised their target price on Colgate-Palmolive from $81.00 to $86.00 and gave the stock an “overweight” rating in a research report on Friday, January 13th. Five investment analysts have rated the stock with a hold rating and eight have assigned a buy rating to the stock. According to MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $82.27.
Colgate-Palmolive Price Performance
Colgate-Palmolive (NYSE:CL – Get Rating) last released its quarterly earnings data on Friday, January 27th. The company reported $0.77 earnings per share (EPS) for the quarter, meeting analysts’ consensus estimates of $0.77. The firm had revenue of $4.63 billion during the quarter, compared to analysts’ expectations of $4.58 billion. Colgate-Palmolive had a return on equity of 317.08% and a net margin of 9.93%. The business’s revenue for the quarter was up 5.1% on a year-over-year basis. During the same quarter last year, the firm earned $0.79 earnings per share. Analysts forecast that Colgate-Palmolive will post 3.1 EPS for the current fiscal year.
Colgate-Palmolive Increases Dividend
The company also recently disclosed a quarterly dividend, which will be paid on Monday, May 15th. Investors of record on Friday, April 21st will be given a dividend of $0.48 per share. This is a boost from Colgate-Palmolive’s previous quarterly dividend of $0.47. The ex-dividend date is Thursday, April 20th. This represents a $1.92 dividend on an annualized basis and a yield of 2.58%. Colgate-Palmolive’s dividend payout ratio (DPR) is presently 88.26%.
Colgate-Palmolive Profile
Colgate-Palmolive Co is engaged in the manufacturing and distribution of consumer products. It operates through the Oral, Personal and Home Care, and Pet Nutrition segments. The Oral, Personal and Home Care segment represents North America, Latin America, Europe, Asia Pacific, and Africa or Eurasia, all of which sell to a variety of retail and wholesale customers and distributors.
Featured Articles
- Get a free copy of the StockNews.com research report on Colgate-Palmolive (CL)
- Dave & Buster’s Rebound Could Score for Investors
- Cal-Maine: Is it Time to Chase this Stock Higher?
- The Most Important Warren Buffett Stock for Investors: His Own
- Three Mid Caps Wall Street Sees Doubling Within 12 Months
- It’s No Stretch: Lululemon Could Break Out of its Range
Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive (NYSE:CL – Get Rating).
Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.
